RxDoctor Payments Data

Jose Rossello, MD

Family Medicine · Fayetteville, GANPI 1831299007

Payments from drug & device makers

$2,396in general payments, 2019–2025

Across 134 payments — averaging $17.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$626
  • AbbVie$219
  • GSK$188
  • AstraZeneca$173
  • Johnson & Johnson$132
  • Novartis$115
  • plus $943 from 22 others

What the payments were for

  • Food & beverage$2,396100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,396 in reported general payments places this provider in the 70th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$109,335
Medicare patients
411
Services billed
1,975

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin196$194,770
OzempicSemaglutide62$101,356
MounjaroTirzepatide83$96,607
TrulicityDulaglutide40$57,577
JanuviaSitagliptin Phosphate29$35,245
FarxigaDapagliflozin Propanediol31$32,071
EliquisApixaban37$29,482
Tresiba Flextouch U-200Insulin Degludec27$29,102
JanumetSitagliptin Phos/Metformin Hcl24$28,004
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog24$20,218
Tresiba Flextouch U-100Insulin Degludec18$13,452
SynthroidLevothyroxine Sodium78$8,021
EntrestoSacubitril/Valsartan11$6,828
PremarinEstrogens, Conjugated18$5,603
Rosuvastatin Calcium363$4,942

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$50$194,770196 claims
Lilly USA, LLCMounjaro, Trulicity$115$154,184123 claims
Novo NordiskOzempic$626$101,35662 claims
MerckJanuvia, Janumet$22$63,24853 claims
PfizerEliquis, Premarin$80$35,08555 claims
AstraZenecaFarxiga$173$32,07131 claims
AbbVieSynthroid$219$8,02178 claims
NovartisEntresto$115$6,82811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Fayetteville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →